Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Comprehensive Cytopathology
172
Zitationen
1
Autoren
1997
Jahr
Abstract
Book Reviews| August 30 2011 Comprehensive Cytopathology: Second edition. Edited by Marluce Bibbo, M.D., Sc.D., F.I.A.C., Philadelphia, WB Saunders, 1997, 1,084 pages Subject Area: Pathology and Cell Biology Ulrik Baandrup Ulrik Baandrup Search for other works by this author on: This Site PubMed Google Scholar Acta Cytologica (1997) 41 (1): 228. https://doi.org/10.1159/000332325 Article history Published Online: August 30 2011 Content Tools Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Tools Icon Tools Get Permissions Cite Icon Cite Search Site Citation Ulrik Baandrup; Comprehensive Cytopathology: Second edition. Edited by Marluce Bibbo, M.D., Sc.D., F.I.A.C., Philadelphia, WB Saunders, 1997, 1,084 pages. Acta Cytologica 1 February 1997; 41 (1): 228. https://doi.org/10.1159/000332325 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsActa Cytologica Search Advanced Search Article PDF first page preview Close Modal Keywords: textbooks, Comprehensive Cytopathology This content is only available via PDF. 1997Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. You do not currently have access to this content.
Ähnliche Arbeiten
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 · 13.213 Zit.
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
2005 · 7.606 Zit.
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
2002 · 6.513 Zit.
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 · 6.337 Zit.
Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer
2002 · 6.194 Zit.